BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 27262160)

  • 21. Determination of Margins for Tumor Clearance in Dermatofibrosarcoma Protuberans: A Single-Center Study of 222 Cases Treated With Modified Mohs Surgery.
    Serra-Guillén C; Llombart B; Nagore E; Guillén C; Sanmartín O
    Dermatol Surg; 2022 Jan; 48(1):51-56. PubMed ID: 34743125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgical treatment for dermatofibrosarcoma protuberans: the Dartmouth experience and literature review.
    Yu W; Tsoukas MM; Chapman SM; Rosen JM
    Ann Plast Surg; 2008 Mar; 60(3):288-93. PubMed ID: 18443511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. From Morphea to Dermatofibrosarcoma Protuberans.
    Crnarić I; Šitum M; Delaš Aždajić M; Vučić M; Buljan M
    Acta Dermatovenerol Croat; 2022 Sep; 30(2):113-115. PubMed ID: 36254545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modified Mohs micrographic surgery in the therapy of dermatofibrosarcoma protuberans: analysis of 22 patients.
    Wacker J; Khan-Durani B; Hartschuh W
    Ann Surg Oncol; 2004 Apr; 11(4):438-44. PubMed ID: 15070606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dermatofibrosarcoma protuberans: a clinicopathological, immunohistochemical, genetic (COL1A1-PDGFB), and therapeutic study of low-grade versus high-grade (fibrosarcomatous) tumors.
    Llombart B; Monteagudo C; Sanmartín O; López-Guerrero JA; Serra-Guillén C; Poveda A; Jorda E; Fernandez-Serra A; Pellín A; Guillén C; Llombart-Bosch A
    J Am Acad Dermatol; 2011 Sep; 65(3):564-575. PubMed ID: 21570152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Dermatofibrosarcoma protuberans: Surgical margins using Slow-Mohs micrographic surgery. A clinical retrospective study about 20 cases].
    Verbruggen C; Ricard AS; Cogrel O; Bondaz M; Carrier S
    Ann Chir Plast Esthet; 2018 Feb; 63(1):47-53. PubMed ID: 28755830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dermatofibrosarcoma protuberans: 35 patients treated with Mohs micrographic surgery using paraffin sections.
    Tan WP; Barlow RJ; Robson A; Kurwa HA; McKenna J; Mallipeddi R
    Br J Dermatol; 2011 Feb; 164(2):363-6. PubMed ID: 20973768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Malignancy arising within cutaneous tattoos: case of dermatofibrosarcoma protuberans and review of literature.
    Reddy KK; Hanke CW; Tierney EP
    J Drugs Dermatol; 2011 Aug; 10(8):837-42. PubMed ID: 21818504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multidisciplinary approach to the management of dermatofibrosarcoma protuberans.
    Buck DW; Kim JY; Alam M; Rawlani V; Johnson S; Connor CM; Dumanian GA; Wayne JD
    J Am Acad Dermatol; 2012 Nov; 67(5):861-6. PubMed ID: 22387033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiological trends and survival outcomes for dermatofibrosarcoma protuberans of the head and neck region.
    Go CC; Lahaie Luna GM; Briceño CA
    Int J Dermatol; 2023 May; 62(5):664-671. PubMed ID: 36318642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dermatofibrosarcoma Protuberans: Wide Local Excision Versus Mohs Micrographic Surgery.
    Mullen JT
    Surg Oncol Clin N Am; 2016 Oct; 25(4):827-39. PubMed ID: 27591501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety margins for dermatofibrosarcoma protuberans: a comparison between wide local excision and Mohs Tubingen technique.
    Cammarata E; Esposto E; Veronese F; Airoldi C; Zavattaro E; Boggio P; Savoia P
    Eur J Dermatol; 2020 Jun; 30(3):289-293. PubMed ID: 32576543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A systematic review of outcome data for dermatofibrosarcoma protuberans with and without fibrosarcomatous change.
    Liang CA; Jambusaria-Pahlajani A; Karia PS; Elenitsas R; Zhang PD; Schmults CD
    J Am Acad Dermatol; 2014 Oct; 71(4):781-6. PubMed ID: 24755121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mohs micrographic surgery for dermatofibrosarcoma protuberans: comparison of frozen and paraffin techniques.
    Lee SH; Oh Y; Nam KA; Oh B; Roh MR; Chung KY
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2171-2177. PubMed ID: 30067886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of dermatofibroma sarcoma protuberans using modified Mohs micrographic surgery: no recurrences and smaller defects.
    Hancox JG; Kelley B; Greenway HT
    Dermatol Surg; 2008 Jun; 34(6):780-4. PubMed ID: 18318720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes in 11 patients with dermatofibrosarcoma protuberans treated with Mohs micrographic surgery.
    Galimberti G; Montaño AP; Kowalczuk A; Ferrario D; Galimberti R
    Int J Dermatol; 2012 Jan; 51(1):89-93. PubMed ID: 22182384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibrosarcomatous ("high-grade") dermatofibrosarcoma protuberans: clinicopathologic and immunohistochemical study of a series of 41 cases with emphasis on prognostic significance.
    Mentzel T; Beham A; Katenkamp D; Dei Tos AP; Fletcher CD
    Am J Surg Pathol; 1998 May; 22(5):576-87. PubMed ID: 9591728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Comparison of Mohs Micrographic Surgery and Wide Local Excision for Treatment of Dermatofibrosarcoma Protuberans With Long-Term Follow-up: The Mayo Clinic Experience.
    Lowe GC; Onajin O; Baum CL; Otley CC; Arpey CJ; Roenigk RK; Brewer JD
    Dermatol Surg; 2017 Jan; 43(1):98-106. PubMed ID: 27749444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surgical Outcomes of Primary Dermatofibrosarcoma Protuberans: A Retrospective, Multicenter Study.
    Houdek MT; Tsoi KM; Mallett KE; Claxton RM; Ferguson PC; Griffin AM; Baum CL; Brewer JD; Rose PS; Wunder JS
    Ann Surg Oncol; 2022 Dec; 29(13):8632-8638. PubMed ID: 35933538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subcutaneous dermatofibrosarcoma protuberans, a rare subtype with predilection for the head: A retrospective series of 18 cases.
    Llombart B; Serra-Guillén C; Rubio L; Nagore E; Requena C; Traves V; Calomarde L; Bancalari B; López-Guerrero JA; Guillen-Barona C; Sanmartín O
    J Am Acad Dermatol; 2017 Sep; 77(3):503-511.e1. PubMed ID: 28420485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.